PENUMBRA INC (PEN)

US70975L1070 - Common Stock

203  -3.15 (-1.53%)

Full profile views are only available for registered users, you can see which data is available below.

Examples of complete profiles are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional data.

PENUMBRA INC

NYSE:PEN (4/25/2024, 9:23:41 AM)

203

-3.15 (-1.53%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Overview
Earnings (Last)
Earnings (Next)
Ins Owners
Inst Owners
Market Cap7.86B
Shares
PE97.13
Fwd PE71.06
Dividend YieldN/A
Analysts
IPO
Stock Screener Links
Screen Image

New York Stock Exchange, Inc. Stock Screener

Find more stocks on New York Stock Exchange, Inc.

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Growth Stock Screener

Find more growth stocks the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

PEN Daily chart

Company Profile

Penumbra, Inc. engages in the design, development, manufacture, and marketing of innovative medical devices. The company is headquartered in Alameda, California and currently employs 3,900 full-time employees. The company went IPO on 2015-09-18. The firm designs, develops, manufactures, and markets products and has a portfolio that focuses on medical conditions in markets with unmet need. The company is focused on developing, manufacturing, and marketing products for use by specialist physicians and healthcare providers. The company is focused on developing and building its portfolio of products, including its thrombectomy, embolization, access, and immersive healthcare technologies. The company has developed a product portfolio that includes seven product families within its major markets, in which its neuro products include Thrombectomy, Embolization, Access, and Neurosurgical Tools. Its vascular products include Thrombectomy and Embolization. The firm's immersive healthcare product is Immersive 3D Computer-based Technology Platform. The firm sells its products to hospitals and healthcare providers primarily through its direct sales organization in the United States, Europe, Canada and Australia.

Company Info

PENUMBRA INC

One Penumbra Place

Alameda CALIFORNIA 94502

P: 15107483200

CEO: Adam Elsesser

Employees: 3900

Website: https://www.penumbrainc.com/

PEN News

News Image7 days ago - Market News VideoPenumbra Becomes Oversold (PEN)
News Image16 days ago - Penumbra, Inc.Penumbra, Inc. Schedules First Quarter 2024 Earnings Release and Conference Call for May 7, 2024

/PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial results for the first quarter 2024 after...

News Imagea month ago - Market News VideoPEN July 2025 Options Begin Trading
News Imagea month ago - Market News VideoNotable Friday Option Activity: PEN, PRGS, ULTA
News Image2 months ago - Market News VideoNoteworthy Friday Option Activity: ATMU, NAT, PEN
News Image2 months ago - Seeking AlphaPenumbra stock cut to Hold at J.P. Morgan (NYSE:PEN)

Penumbra (PEN) stock slips as J.P. Morgan downgrades the medical device company as its Q4 2023 revenue falls short of estimates. Read more here.

PEN Twits

Here you can normally see the latest stock twits on PEN, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example